These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 26428619)

  • 1. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell derived cardiac models: effects of Thymosin β4.
    Ziegler T; Hinkel R; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):111-120. PubMed ID: 30063852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.
    Ovics P; Regev D; Baskin P; Davidor M; Shemer Y; Neeman S; Ben-Haim Y; Binah O
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023024
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
    White MC; Pang L; Yang X
    Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.
    Shaheen N; Shiti A; Gepstein L
    Clin Pharmacol Ther; 2017 Aug; 102(2):203-208. PubMed ID: 28718902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
    Zhou J; Cui B; Wang X; Wang H; Zheng J; Guo F; Sun Y; Fan H; Shen J; Su J; Wang J; Zhao H; Tang Y; Gong T; Sun N; Liang P
    Stem Cell Res Ther; 2023 Apr; 14(1):92. PubMed ID: 37061738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.
    Smith AS; Macadangdang J; Leung W; Laflamme MA; Kim DH
    Biotechnol Adv; 2017; 35(1):77-94. PubMed ID: 28007615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human engineered heart tissue as a model system for drug testing.
    Eder A; Vollert I; Hansen A; Eschenhagen T
    Adv Drug Deliv Rev; 2016 Jan; 96():214-24. PubMed ID: 26026976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
    Magdy T; Schuldt AJT; Wu JC; Bernstein D; Burridge PW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():83-103. PubMed ID: 28992430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC
    Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Applications of Tissue Engineering in Cardiovascular Medicine.
    Dogan A; Elcin AE; Elcin YM
    Curr Pharm Des; 2017 Mar; 23(6):903-914. PubMed ID: 27834123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.
    Kurokawa YK; George SC
    Adv Drug Deliv Rev; 2016 Jan; 96():225-33. PubMed ID: 26212156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.
    Thomas D; Cunningham NJ; Shenoy S; Wu JC
    Cardiovasc Res; 2022 Jan; 118(1):20-36. PubMed ID: 33757124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery.
    Li J; Hua Y; Miyagawa S; Zhang J; Li L; Liu L; Sawa Y
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio-Oncology.
    Nair P; Prado M; Perea-Gil I; Karakikes I
    Stem Cells Transl Med; 2019 Aug; 8(8):758-767. PubMed ID: 31020786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.
    Abi-Gerges N; Miller PE; Ghetti A
    Curr Pharm Biotechnol; 2020; 21(9):787-806. PubMed ID: 31820682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.